Clinical Methods and Design for a Phase II Randomised Control Trial to Assess the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in Idiopathic Intracranial Hypertension: IIH:DT.

Keira Markey, Ryan Ottridge, James Mitchell, Caroline Rick, Rebecca Woolley, Natalie Ives, P Nightingale, Alex Sinclair

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalJMIR Research Protocols
Publication statusPublished - 18 Sep 2017

Cite this